Blog

RevIT AAV: Transforming Gene Therapy Production Efficiency
🔍Discover RevIT AAV: A game-changing enhancer for gene therapy production, increasing efficiency by 2-4X. 🧬🔬🧪

Revolutionary IRO Platform Accelerates Cell and Gene Therapy Manufacturing
🌟 Ori Biotech launches IRO platform to tackle cell and gene therapy manufacturing challenges. 🧬 Flexibility, scalability, and faster development timelines. 💪🚀 Increasing patient access to life-saving therapies. 💉🧬

Regulators Threaten Biosimilars Boost for LMICs
📰 Western regulators threaten the future of biosimilars, pushing innovation and cost reduction to low and medium-income countries. 😱🌍

Unlocking Vibrio’s Potential: The Future of Bioprocessing
Converging Roads in Bioprocessing explores the potential of using Vibrio in synthetic biology and bioprocessing. 🦠🧪🔬

Revolutionizing Biomanufacturing: Data Management is Key
📊 Biomanufacturing must rethink data management to keep up with the increasing complexity and volume of data generated in the industry. 🏭

Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing
📅 May 29, 2024: 🧪 Small biotech companies should engage a CDMO early for cell therapy GMP manufacturing. 📝 Documentation, quality control, and trust are key.

Shocking Study: Stress and Pumping Impact Protein Concentrations!
🔍 Stress and pumping order impact protein concentrations in biologic drugs. Learn how to reduce particle formation and optimize manufacturing! 😊

UK’s Semarion Ltd Wins Innovation Award for Revolutionary Lab Automation Platform
🏆 Semarion Ltd. wins Ignite SME award for innovative lab automation at SLAS Europe 2024. 🧪✨ Faster drug development with Semacyte platform! 💡👩🔬🔬

MSD Snatches Eyebiotech Ltd for $3bn Dominates Vision Loss Market
💰 US pharma giant MSD acquires Eyebiotech Ltd for up to $3bn, gaining their clinical pipeline of vision loss candidates. 👁️🗨️🩺 Unanimously approved by EyeBio Board.






